Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept dosing strategies in liver transplant
NCT00545402Phase 4Completed
- Sponsor
- Roche
- Start
- Nov 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in Liver transplant rejection, sponsored by Roche. Started Nov 2007; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00545402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545402.